You’ve hit your search limit
Start your free trial to keep exploring full traffic and performance insights.
Get Started- Inicio
- Análisis gratuito de aplicaciones
- IV Medications Gahart
Análisis de la app IV Medications Gahart para 19 de mayo
IV Medications Gahart
- Unbound Medicine, Inc.
- App Store de Apple
- Gratis
- Medicina
Trusted for over 45 years, Intravenous Medications contains everything needed for the safe and effective administration of IV drugs. Updated annually, this comprehensive resource contains detailed monographs that include dosage, administration, contraindications, precautions, interactions, antidotes, and more. This app helps nurses, nursing students, and health professionals avoid errors by using the built-in calculator to determine precise dilution and rate of administration. Download this app to see how it will build confidence and help you provide better patient care with its intuitive, quick-access format.
Features of Intravenous Medications include:
• 400+ detailed generic and trade name IV drug monographs
• Annual updates
• New monographs featuring recently FDA approved drugs
• Helpful calculator and charts for dilution and rate of administration
• Black Box Warnings highlighting critical information
• Blue-screened text call attention to important circumstances that may not warrant Black Box Warnings.
• Life-stage dosage variances for geriatric, pediatric, infant, and neonatal patients
• Updated drug interactions, precautions, alerts, and patient teaching instructions for all IV drugs
• Dilution and dosage charts within monographs provide quick access to essential clinical information
• Advanced Search help you find terms fast
• “Favorites” for bookmarking important entries
• Personalize your app with notes and highlights
FREE 14-DAY TRIAL: WHAT TO EXPECT
• First-time users can access Unbound's complete IV Medications mobile app free for 14 days
• After 14 days, your iTunes account will be charged $49.99 for a one-year subscription unless you have turned off auto-renew at least 24 hours before the free trial ends.
• To manage your subscriptions, open Apple's “Settings” app and tap on the “iTunes & App Store" entry. Tap your Apple ID at the top of the screen and login. Tap subscriptions, then tap the subscription you wish to manage.
• NOTE: If you choose not to purchase a subscription, content will no longer be viewable after the free trial period.
iTunes automatic renewal feature: Your subscription automatically renews unless auto-renew is turned off 24 hours prior to the conclusion of your current 12 month period. Your iTunes account will automatically be charged the current renewal rate ($49.99) within 24 hours prior to the end of the subscription period. This will ensure you receive all updates and continued web access for the following year. If you choose not to renew, you will be able to use the app, however will not receive updates.
Authors: Shelly Rainforth Collins, PharmD, BCGP
Publisher: Elsevier
Powered by: Unbound Medicine
Unbound Privacy Policy: www.unboundmedicine.com/privacy
Unbound Terms of Use: https://www.unboundmedicine.com/end_user_license_agreement
Clasificación de tiendas
El Store Rank se basa en múltiples parámetros establecidos por Google y Apple.
Todas las categorías en
Estados Unidos--
Medicina en
Estados Unidos--
Crea una cuenta para ver la media de las descargas mensualesContáctenos
Estadísticas de clasificación de IV Medications Gahart a lo largo del tiempo
Rango de uso de Similarweb & Rango de App Store de Apple para IV Medications Gahart
Clasificación
No hay datos disponibles
Clasificación por país IV Medications Gahart
Países en los que IV Medications Gahart tiene la clasificación más alta en sus categorías principales
No hay datos para mostrar
Principales competidores & aplicaciones alternativas
Aplicaciones con una alta probabilidad de ser utilizadas por los mismos usuarios, desde la misma tienda.
IV Medications Elsevier
Skyscape Medpresso Inc
Handbook on Injectable Drugs
Skyscape Medpresso Inc
PEPID®
PEPID, LLC
Dosage Calculations Made Easy
Skyscape Medpresso Inc
mayo 19, 2026